These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7658449)

  • 1. Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase: a new class of antiviral agents.
    Moss N; Beaulieu P; Duceppe JS; Ferland JM; Gauthier J; Ghiro E; Goulet S; Grenier L; Llinas-Brunet M; Plante R
    J Med Chem; 1995 Sep; 38(18):3617-23. PubMed ID: 7658449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo.
    Liuzzi M; Déziel R; Moss N; Beaulieu P; Bonneau AM; Bousquet C; Chafouleas JG; Garneau M; Jaramillo J; Krogsrud RL
    Nature; 1994 Dec; 372(6507):695-8. PubMed ID: 7990963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the molecular mechanism of viral resistance to peptidomimetic inhibitors of ribonucleotide reductase.
    White PW
    Biochim Biophys Acta; 1998 Jan; 1382(1):102-10. PubMed ID: 9507079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiviral activity of the ribonucleotide reductase inhibitor BILD 1351 SE in combination with acyclovir against HSV type-1 in cell culture.
    Lawetz C; Liuzzi M
    Antiviral Res; 1998 Jul; 39(1):35-46. PubMed ID: 9754948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.
    Duan J; Liuzzi M; Paris W; Lambert M; Lawetz C; Moss N; Jaramillo J; Gauthier J; Déziel R; Cordingley MG
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase with improved in vivo antiviral activity.
    Moss N; Beaulieu P; Duceppe JS; Ferland JM; Garneau M; Gauthier J; Ghiro E; Goulet S; Guse I; Jaramillo J; Llinas-Brunet M; Malenfant E; Plante R; Poirier M; Soucy F; Wernic D; Yoakim C; Déziel R
    J Med Chem; 1996 Oct; 39(21):4173-80. PubMed ID: 8863795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: selection and characterization of mutant isolates.
    Bonneau AM; Kibler P; White P; Bousquet C; Dansereau N; Cordingley MG
    J Virol; 1996 Feb; 70(2):787-93. PubMed ID: 8551616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease.
    Brandt CR; Spencer B; Imesch P; Garneau M; Déziel R
    Antimicrob Agents Chemother; 1996 May; 40(5):1078-84. PubMed ID: 8723444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ribonucleotide reductase inhibitor (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731): a potential topical therapy for herpes simplex virus infection.
    Bridges CG; Ahmed SP; Sunkara PS; McCarthy JR; Tyms AS
    Antiviral Res; 1995 Aug; 27(4):325-34. PubMed ID: 8540753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribonucleotide reductase inhibitors as anti-herpes agents.
    Wnuk SF; Robins MJ
    Antiviral Res; 2006 Sep; 71(2-3):122-6. PubMed ID: 16621038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus.
    Petrowsky H; Roberts GD; Kooby DA; Burt BM; Bennett JJ; Delman KA; Stanziale SF; Delohery TM; Tong WP; Federoff HJ; Fong Y
    J Virol; 2001 Aug; 75(15):7050-8. PubMed ID: 11435585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of herpes simplex virus type 1 ribonucleotide reductase by substituted tetrapeptide derivatives.
    Moss N; Déziel R; Adams J; Aubry N; Bailey M; Baillet M; Beaulieu P; DiMaio J; Duceppe JS; Ferland JM
    J Med Chem; 1993 Oct; 36(20):3005-9. PubMed ID: 8411018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides.
    Dutia BM; Frame MC; Subak-Sharpe JH; Clark WN; Marsden HS
    Nature; 1986 May 22-28; 321(6068):439-41. PubMed ID: 3012359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of herpes simplex virus thymidine kinases by 2-phenylamino-6-oxopurines and related compounds: structure-activity relationships and antiherpetic activity in vivo.
    Manikowski A; Verri A; Lossani A; Gebhardt BM; Gambino J; Focher F; Spadari S; Wright GE
    J Med Chem; 2005 Jun; 48(11):3919-29. PubMed ID: 15916444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo.
    Watkins AM; Dunford PJ; Moffatt AM; Wong-Kai-In P; Holland MJ; Pole DS; Thomas GM; Martin J; Roberts NA; Mulqueen MJ
    Antivir Chem Chemother; 1998 Jan; 9(1):9-18. PubMed ID: 9875372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ureido-based peptidomimetic inhibitor of herpes simplex virus ribonucleotide reductase: an investigation of inhibitor bioactive conformation.
    Moss N; Beaulieu P; Duceppe JS; Ferland JM; Gauthier J; Ghiro E; Goulet S; Guse I; Llinàs-Brunet M; Plante R; Plamondon L; Wernic D; Déziel R
    J Med Chem; 1996 May; 39(11):2178-87. PubMed ID: 8667361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity of synthetic peptides for the HSV-2 ribonucleotide reductase R1 subunit measured with an iodinated photoaffinity peptide.
    Lamarche N; Gaudreau P; Massie B; Langelier Y
    Anal Biochem; 1994 Aug; 220(2):315-20. PubMed ID: 7978273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel protein kinase of the RR1 subunit of herpes simplex virus has autophosphorylation and transphosphorylation activity that differs in its ATP requirements for HSV-1 and HSV-2.
    Peng T; Hunter JR; Nelson JW
    Virology; 1996 Feb; 216(1):184-96. PubMed ID: 8614985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
    J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of podophyllotoxin derivatives on herpes simplex virus replication.
    Sudo K; Konno K; Shigeta S; Yokota T
    Antivir Chem Chemother; 1998 May; 9(3):263-7. PubMed ID: 9875405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.